Inovio's coronavirus vaccine candidate delivers promising results in Phase 1 trial

Inovio released a coronavirus vaccine update to announce that its experimental DNA drug generated immune responses in 94% of volunteers enrolled in Phase 1 ... Read more

Bron:

BGR | Boy Genius Report